Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Robert L. Panek, Michael J. Ryan, Ronald E. Weishaar & David G. Taylor. (1991) Development of a High Renin Model of Hypertension in the Cynomolgus Monkey. Clinical and Experimental Hypertension. Part A: Theory and Practice 13:8, pages 1395-1414.
Read now
Read now
P. Zachariah, S. Ritter, M. Fiksen-olsen, C. Strong & J. C. Romero. (1989) Stimulation of Plasma Renin Activity by Captopril in Renovascular Hypertensive Conscious Dogs. Clinical and Experimental Hypertension. Part A: Theory and Practice 11:2, pages 205-213.
Read now
Read now
David P Clough, Sheila C Mulroy & David Angell. (1983) Interference by Inhibitors of the Renin-Angiotensin System with Neurogenic Vasoconstriction. Clinical and Experimental Hypertension. Part A: Theory and Practice 5:7-8, pages 1287-1299.
Read now
Read now
James P. Henry, Patricia M. Stephens & Arthur J. Vander. (1983) Inhibition of Angiotensin - Converting Enzyme in CBA Mice with Psychosocial Hypertension. Clinical and Experimental Hypertension. Part A: Theory and Practice 5:1, pages 87-97.
Read now
Read now
Articles from other publishers (17)
Yonggang Wang, Hao Wu, Ying Xin, Yang Bai, Lili Kong, Yi Tan, Feng Liu & Lu Cai. (2017) Sulforaphane Prevents Angiotensin II-Induced Testicular Cell Death via Activation of NRF2. Oxidative Medicine and Cellular Longevity 2017, pages 1-12.
Crossref
Crossref
Zhengchao Wang, Qing ZhuPin-Lan LiRomesh DhadukFan ZhangTodd W. Gehr & Ningjun Li. (2014) Silencing of hypoxia-inducible factor-1α gene attenuates chronic ischemic renal injury in two-kidney, one-clip rats. American Journal of Physiology-Renal Physiology 306:10, pages F1236-F1242.
Crossref
Crossref
Ji Min Kim, Hyoung-Sam Heo, Young Mi Ha, Byeong Hyeok Ye, Eun Kyeong Lee, Yeon Ja Choi, Byung Pal Yu & Hae Young Chung. (2011) Mechanism of Ang II involvement in activation of NF-?B through phosphorylation of p65 during aging. AGE 34:1, pages 11-25.
Crossref
Crossref
Dileep Kumar, Divya Salhan, Sandeep Magoon, Deepti D. Torri, Swapna Sayeneni, Ankita Sagar, Anshu Bandhlish, Ashwani Malhotra, Praveen N. Chander & Pravin C. Singhal. (2011) Adverse Host Factors Exacerbate Occult HIV-Associated Nephropathy. The American Journal of Pathology 179:4, pages 1681-1692.
Crossref
Crossref
Dan Wang, Pedro Jose & Christopher S. Wilcox. (2006)
β
1
Receptors Protect the Renal Afferent Arteriole of Angiotensin-Infused Rabbits from Norepinephrine-Induced Oxidative Stress
. Journal of the American Society of Nephrology 17:12, pages 3347-3354.
Crossref
Crossref
Matthew G. Melaragno & Gregory D. Fink. (2007) SLOW PRESSOR EFFECT OF ANGIOTENSIN II IN NORMOTENSIVE RATS WITH RENAL ARTERY STENOSIS. Clinical and Experimental Pharmacology and Physiology 23:2, pages 140-144.
Crossref
Crossref
T Okamura, M Miyazaki, T Inagami & N Toda. (1986) Vascular renin-angiotensin system in two-kidney, one clip hypertensive rats.. Hypertension 8:7, pages 560-565.
Crossref
Crossref
Milton Packer, Norma Medina & Madeline Yushak. (1984) Efficacy of captopril in low-renin congestive heart failure: Importance of sustained reactive hyperreninemia in distinguishing responders from nonresponders. The American Journal of Cardiology 54:7, pages 771-777.
Crossref
Crossref
C. I. JOHNSTON. (2008) TREATMENT OF HYPERTENSION WITH ANGIOTENSIN CONVERTING ENZYME INHIBITORS. Australian and New Zealand Journal of Medicine 14:4, pages 509-513.
Crossref
Crossref
L K Ben, J Maselli, L C Keil & I A Reid. (1984) Role of the renin-angiotensin system in the control of vasopressin and ACTH secretion during the development of renal hypertension in dogs.. Hypertension 6:1, pages 35-41.
Crossref
Crossref
D P Clough, R Hatton, J R Keddie & M G Collis. (1982) Hypotensive action of captopril in spontaneously hypertensive and normotensive rats. Interference with neurogenic vasoconstriction.. Hypertension 4:6, pages 764-772.
Crossref
Crossref
David P. Clough, Michael G. Collis, James Conway, Raymond Hation & John R. Keddie. (1982) Interaction of angiotensin-converting enzyme inhibitors with the function of the sympathetic nervous system. The American Journal of Cardiology 49:6, pages 1410-1414.
Crossref
Crossref
Joelle Baranes, Pierre Thiévant, Micheline Le Hegarat, Sylvie Delaflotte, Annie Etienne, François Clostre & Francis V. DeFeudis. (1982) A comparison of the dose-response effects of captopril in anaesthetized normotensive and renovascular hypertensive rats. General Pharmacology: The Vascular System 13:5, pages 439-443.
Crossref
Crossref
A. ANGELI, D. BISBOCCI, F. ORLANDI, P. PACCOTTI, R. TABASSO, C. TAMAGNONE & G. C. LAVEZZARO. (2008) PITUITARY—ADRENOCORTICAL FUNCTION IN PATIENTS DURING TREATMENT WITH THE ANGIOTENSIN‐CONVERTING ENZYME INHIBITOR CAPTOPRIL. Clinical Endocrinology 15:6, pages 555-565.
Crossref
Crossref
A B Atkinson, J J Brown, D L Davies, B Leckie, A F Lever, J J Morton & J I Robertson. (1981) Renal artery stenosis with normal angiotensin II values. Relationship between angiotensin II and body sodium and potassium on correction of hypertension by captopril and subsequent surgery.. Hypertension 3:1, pages 53-58.
Crossref
Crossref
A B Atkinson, J J Morton, J J Brown, D L Davies, R Fraser, P Kelly, B Leckie, A F Lever & J I Robertson. (1980) Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.. Heart 44:3, pages 290-296.
Crossref
Crossref
A.B Atkinson & J.I.S Robertson. (1979) CAPTOPRIL IN THE TREATMENT OF CLINICAL HYPERTENSION AND CARDIAC FAILURE. The Lancet 314:8147, pages 836-839.
Crossref
Crossref